ACE and early-onset autosomal dominant Alzheimer disease: Walker et al. postulated that angiotensin converting enzyme inhibitors may act through a different mechanism, since no link was found between Alzheimer’s disease risk and systolic blood pressure or other antihypertensives (Walker et al., 2019).